Antigens of Normal and Malignant Human Exocrine Pancreatic Cells

  • Michael A. Hollingsworth
  • Richard S. Metzgar
Part of the Contemporary Biomedicine book series (CB, volume 6)

Abstract

Pancreatic cancer is currently the fourth leading cause of cancer-related death in the United States (Cohn, 1976). The diagnosis of pancreatic adenocarcinoma is usually a late event in the disease, which has a 5-yr survival rate of less than 2% (Hirayama et al., 1980). Early signs and symptoms of this disease are often vague or lacking, except for occasional obstructive jaundice or major vascular involvement. Ascites, liver involvement, and other signs of advanced disease are often the presenting physical findings. It is not yet clear whether the low survival rate is due to a late stage of disease presentation, the early development of metastases, or other factors. The few survivors, however, are almost exclusively patients in whom a tumor was detected fortuitously and surgically excised at an early, premetastatic stage. This fact suggests that early diagnosis could substantially improve the prognosis for the disease and has stimulated many attempts at defining systems for early diagnosis including: exploratory surgery and biopsy (Mikal, 1964; Wave, 1975); ultrasonic scanning (Filly and Fiemanis, 1970); selective arteriography with hypotonic duodenography (Suzuki et al., 1974); computerized transaxial tomography (Sorabella et al., 1974); endoscopic retrograde cholangiopancreatography (Fukumoto et al., 1974); and pancreatic functional tests (Cohn, 1976). Unfortunately, to date such attempts have not been useful as cancer-screening tests.

Keywords

Carbohydrate Lymphoma Electrophoresis Sarcoma Gall 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Arndt, R., K. Nishida, W. M. Becker, and H. G. Thiele (1979), 6th Meeting Int. Soc. Oncodevel. Biol. Med. abstract, 229.Google Scholar
  2. Atkinson, B. F., C. S. Ernst, M. Herlyn, Z. Steplewski, H. F. Sears, and H. Koprowski (1982), Cancer Research 42, 4820.PubMedGoogle Scholar
  3. Banwo, O., J. Versey, and J. R. Hobbs (1974), Lancet 1, 643.PubMedCrossRefGoogle Scholar
  4. Bast, R. C. Jr., M. Feeney, H. Lazarus, L. M. Nadler, R. B. Cobrin, and R. C. Knapp (1981), J. Clin. Invest.68, 1331.PubMedCrossRefGoogle Scholar
  5. Bast, R. C. Jr., T. L. Klug, E. St. John, E. Jenison, J. M. Niloff, H. Lazarus, R. S. Berkowitz, T. Leavitt, C. T. Griffiths, L. Parker, V. R. Zurawski, and R. C. Knapp (1983), New England J. Med.309, 883.CrossRefGoogle Scholar
  6. Boland, C. R., C. K. Montgomery, and Y. S. Kim (1982), Proc. Natl. Acad. Sci. USA 79, 2051.PubMedCrossRefGoogle Scholar
  7. Borowitz, M. J., F. L. Tuck, W. F. Sindelar, P. D. Fernsten, and R. S. Metzgar (1984), JNCI 72, 999.PubMedGoogle Scholar
  8. Chu, T. M., E. D. Holyoke, and H. O. Douglass (1977), Cancer Research 37, 1525.PubMedGoogle Scholar
  9. Cohn, I. (1976), Cancer 37, 582.PubMedCrossRefGoogle Scholar
  10. Cooper, C. S., D. G. Blair, M. K. Oskarsson, M. A. Tanisky, L. A. Eoder, and G. F. Van de Woude (1984), Cancer Research 44, 1.PubMedGoogle Scholar
  11. Fernsten, P. D. (1984), Dissertation Abstracts International 44, 3034-B.Google Scholar
  12. Filly, R. A. and A. K. Fieimanis (1970), Radiology 96, 575.PubMedGoogle Scholar
  13. Fukumoto, K., M. Nakajama, K. Murakami, and K. Kawai (1974), Am. J. Gastroent. 62, 210.Google Scholar
  14. Gelder, F. B., L. J. Reese, A. R. Moosa, T. Hall, and R. Hunter (1978), Cancer Research 38, 313.PubMedGoogle Scholar
  15. Gold, D. V., P. Hollingsworth, T. Kremer, and D. Nelson (1983), Cancer Research 43, 235.PubMedGoogle Scholar
  16. Gold, D. V. and F. Miller (1978), Tissue Antigens 11, 362.PubMedCrossRefGoogle Scholar
  17. Grant, A. G. and D. Duke (1981), Br. J. Canc. 44, 388.CrossRefGoogle Scholar
  18. Greene, E. L., S. P. Halbert, and D. Kiffer (1975), Int. Arch. Allergy Appl. Immunol. 48, 764.PubMedCrossRefGoogle Scholar
  19. Hakkinen, I. and S. Virtanen (1967), Clin, Exp. Immunol. 2, 669.Google Scholar
  20. Harvey, S. R., L. R. Van Dusen, H. O. Douglass, E. D. Holyoke, and T. M. Chu (1978), JNCI 61, 1199.PubMedGoogle Scholar
  21. Herlyn, M., Z. Steplewski, D. Herlyn, and H. Koprowski (1979), Proc. Natl. Acad. Sci. USA 76, 1438.PubMedCrossRefGoogle Scholar
  22. Herlyn, M., H. F. Sears, Z. Steplewski, and H. Koprowski (1982), J. Clin. Immunol. 2, 135.PubMedCrossRefGoogle Scholar
  23. Hirayama, T., J. A. W. Waterhouse, and J. F. Fraumeni (1980), UICC Technical Report Series 41, 78.Google Scholar
  24. Kabawat, S. E., R. C. Bast, A. K. Bhan, W. R. Welch, R. C. Knapp, and R. B. Cobrin (1983), Lab. Invest. 48, 42A (abstract).Google Scholar
  25. Knapp, M. L. (1981), Ann. Clin. Biochem. 18, 131.PubMedGoogle Scholar
  26. Kuntz, D. J. and S. J. Archer (1979), Oncology 36, 134.PubMedCrossRefGoogle Scholar
  27. Loor, R., M. Kuriyama, M. L. Manzo, H. Inaji, H. O. Douglass, R. Berjian, J. J. Nicolai, G. N. Tytgat, and T. M. Chu (1981), Clin. Chim. Acta. 117, 251.PubMedCrossRefGoogle Scholar
  28. Loor, R., N. J. Nowak, M. L. Manzo, H. O. Doublass, and T. M. Chu (1982), Clinics in Laboratory Med. 2, 567.Google Scholar
  29. Loor, R., T. Shimano, M. L. Manzo, L. Van Dusen, L. D. Papsidero, J. J. Nicolai, G. N. Tytgat, and T. M. Chu (1981), Biochem. etBiophysic. Acta. 668, 222.Google Scholar
  30. Magnani, J. L., M. Brockhaus, D. F. Smith, V. Ginsburg, M. Blaszczyk, K. F. Mitchell, Z. Steplewski, and H. Kropowski (1981), Science 212, 55.PubMedCrossRefGoogle Scholar
  31. Magnani, J. L., Z. Steplewski, H. Koprowski, and V. Ginsburg (1983), Cancer Research 43, 5489.PubMedGoogle Scholar
  32. Metzgar, R. S. (1964a), J. Immunol. 93, 176.Google Scholar
  33. Metzgar, R. S. (1964b), Nature 203, 660.CrossRefGoogle Scholar
  34. Metzgar, R. S. (1980), Transplant. Proc. 12, 122.Google Scholar
  35. Metzgar, R. S., M. T. Gaillard, S. J. Levine, F. L. Tuck, E. H. Bosen, and M. J. Borowitz (1982), Cancer Research 42, 601.PubMedGoogle Scholar
  36. Metzgar, R. S., M. T. Gaillard, S. J. Levine, F. L. Tuck, E. H. Bosen, and M. J. Borowitz (1982), Cancer Research 42, 601.PubMedGoogle Scholar
  37. Mihas, A. (1978), JNCI 60, 1439.PubMedGoogle Scholar
  38. Mikal, S. (1965), Ann. Surg. 161, 395.PubMedCrossRefGoogle Scholar
  39. Nadji, M., P. Ganjei, T. Shimano, and T. M. Chu (1982), Lab. Invest. 60, A.Google Scholar
  40. Nerenberg, S. T., R. Prasad, L. D. Pederson, and N. S. Biskup (1980), Clin. Chem. 26, 209.PubMedGoogle Scholar
  41. Parsa, I. (1982), Cancer Lett. 15, 115.PubMedCrossRefGoogle Scholar
  42. Parsa, I., A. L. Sutton, C. K. Chen, and C. Dellridge (1982), Cancer Lett. 17, 217.PubMedCrossRefGoogle Scholar
  43. Pulciani, S., E. Santos, A. V. Lauver, L. K. Long, S. A. Aaronson, and M. Barbacid (1982), Nature 300, 539.PubMedCrossRefGoogle Scholar
  44. Runge, R. G., and P. Pour (1980), Cancer Lett. 10, 351.PubMedCrossRefGoogle Scholar
  45. Shimano, T., R. M. Loor, L. D. Papsidero, M. Kuriyama, R. G. Vincent, T. Nemoto, E. D. Holyoke, R. Berjian, H. O. Douglass, and T. M. Chu (1981), Cancer 47, 1602.PubMedCrossRefGoogle Scholar
  46. Shultz, D. R. and A. A. Yunis (1979), JNCI 62, 777.Google Scholar
  47. Sorabella, P. A., W. L. Campbell, and W. B. Seman (1974), Radiology 112, 737.Google Scholar
  48. Suzuki, T., K. Uchida, T. Tani, and I. Honjo (1974) Am. J. Roentg. 122, 398.Google Scholar
  49. Wave, M. (1975), Br. Med. J. ii, 354.Google Scholar
  50. Witebsky, E. (1929), Die Naturewissen 40, 771.CrossRefGoogle Scholar
  51. Witebsky, E., N. R. Rose, and H. Nadel (1960), J. Immunol. 85, 568.PubMedGoogle Scholar
  52. Zamcheck, N. and H. Z. Kupchik (1980), Manual of Clinical Immunology Sec-ond Edition, Ed. Noel R. Rose and Herman Friedman, American Society for Microbiology, Washington, DC, p. 919.Google Scholar

Copyright information

© The Humana Press Inc. 1985

Authors and Affiliations

  • Michael A. Hollingsworth
    • 1
  • Richard S. Metzgar
    • 1
  1. 1.Department of Microbiology and ImmunologyDuke University Medical CenterDurhamUSA

Personalised recommendations